Non-Clinical Safety Evaluation of Xoma 3AB, a Novel Triple Antibody Drug Product Targeting Botulinum Toxin Type a, in Sprague-Dawley Rats



Meyer, K., Ng, H., Parman, T., D’Andrea, A., Harrison, T., Green, C., . . . Mirsalis, J. (2013, 2-5 October, 2011). Non-clinical safety evaluation of XOMA 3AB, a novel triple antibody drug product targeting botulinum toxin type A, in Sprague-Dawley rats. Paper presented at the Toxins 2011, Santa Fe, NM

Read more from SRI